
ANI Pharmaceuticals Inc
NASDAQ:ANIP

Intrinsic Value
The intrinsic value of one
ANIP
stock under the Base Case scenario is
111.96
USD.
Compared to the current market price of 57.79 USD,
ANI Pharmaceuticals Inc
is
Undervalued by 48%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ANI Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
ANI Pharmaceuticals Inc
Balance Sheet Decomposition
ANI Pharmaceuticals Inc
Current Assets | 536.3m |
Cash & Short-Term Investments | 155.2m |
Receivables | 220.3m |
Other Current Assets | 160.8m |
Non-Current Assets | 756.1m |
PP&E | 58.2m |
Intangibles | 599.2m |
Other Non-Current Assets | 98.8m |
Free Cash Flow Analysis
ANI Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
ANI Pharmaceuticals Inc
Revenue
|
811.5m
USD
|
Cost of Revenue
|
-323.2m
USD
|
Gross Profit
|
488.3m
USD
|
Operating Expenses
|
-459.2m
USD
|
Operating Income
|
29m
USD
|
Other Expenses
|
-35.5m
USD
|
Net Income
|
-6.4m
USD
|
ANIP Profitability Score
Profitability Due Diligence
ANI Pharmaceuticals Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Score
ANI Pharmaceuticals Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
ANIP Solvency Score
Solvency Due Diligence
ANI Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Score
ANI Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ANIP Price Targets Summary
ANI Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ANIP
is 83.06 USD
with a low forecast of 65.65 USD and a high forecast of 98.7 USD.
Dividends
Current shareholder yield for ANIP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ANIP
stock under the Base Case scenario is
111.96
USD.
Compared to the current market price of 57.79 USD,
ANI Pharmaceuticals Inc
is
Undervalued by 48%.